Home / 2019 / April
 

PEPTONIC medical AB (publ) publicerar årsredovisning för 2018

  • -

PEPTONIC medical (publ)  – meddelar idag att årsredovisningen för 2018 finns tillgänglig på bolagets webbplats www.peptonicmedical.se samt på Spotlight webbplatswww.spotlightstockmarket.com. I revisionsberättelsen lämnas följande information under övriga upplysningar av revisorn: ”Vi

Read More

Recent Posts

Recent Comments

    Archives

    Categories

    Meta

    All press releases on Spotlightstockmarket.com

    All published press releases from PEPTONIC medical is available on spotlightstockmarket.com.

    About us

    PEPTONIC Medical is an innovative Swedish pharmaceutical company developing and commercializing safe and effective products for the treatment of menopausal symptoms, such as vaginal atrophy. VagiVital® is a registered trademark of PEPTONIC Medical. The product is being commercialised for the non-prescription use for the treatment of vaginal atrophy.

    The Company was founded in 2009 and its first candidate drug product is Vagitocin® – an estrogen-free oxytocin based product for the treatment of vaginal atrophy in clinical development phase 2.

    Oxytocin has a long history of safe and effective medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women.